Carmen Visús

1.8k total citations
24 papers, 1.3k citations indexed

About

Carmen Visús is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Carmen Visús has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Carmen Visús's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (5 papers). Carmen Visús is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (5 papers). Carmen Visús collaborates with scholars based in United States, Austria and Germany. Carmen Visús's co-authors include Theresa L. Whiteside, Mirosław J. Szczepański, Marta Szajnik, Eva Wieckowski, Walter J. Storkus, Albert B. DeLeo, Robert L. Ferris, William E. Gooding, Cristina R. Ferrone and Soldano Ferrone and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Carmen Visús

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carmen Visús United States	16	740	607	588	403	104	24	1.3k
Michele Cioffi Spain	13	737 1.0×	409 0.7×	898 1.5×	379 0.9×	106 1.0×	22	1.4k
Elke Firat Germany	21	750 1.0×	561 0.9×	769 1.3×	286 0.7×	143 1.4×	37	1.6k
Elisabeth J. M. Huijbers Netherlands	19	697 0.9×	432 0.7×	486 0.8×	347 0.9×	127 1.2×	35	1.3k
Christina Twyman-Saint Victor United States	4	735 1.0×	747 1.2×	826 1.4×	474 1.2×	75 0.7×	4	1.6k
Pedro Corrêa de Sampaio United States	11	558 0.8×	418 0.7×	837 1.4×	434 1.1×	148 1.4×	12	1.3k
Tony J. Wu United States	3	1.0k 1.4×	779 1.3×	779 1.3×	641 1.6×	93 0.9×	3	1.8k
Munehide Nakatsugawa Japan	21	672 0.9×	683 1.1×	783 1.3×	193 0.5×	83 0.8×	79	1.4k
Marina Kochetkova Australia	19	534 0.7×	331 0.5×	595 1.0×	203 0.5×	76 0.7×	26	1.1k
Helen Kalirai United Kingdom	25	847 1.1×	509 0.8×	613 1.0×	221 0.5×	148 1.4×	89	1.8k
Anne Roslind Denmark	17	636 0.9×	298 0.5×	640 1.1×	391 1.0×	90 0.9×	32	1.3k

Countries citing papers authored by Carmen Visús

Since Specialization

Citations

This map shows the geographic impact of Carmen Visús's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Visús with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Visús more than expected).

Fields of papers citing papers by Carmen Visús

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Visús. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Visús. The network helps show where Carmen Visús may publish in the future.

Co-authorship network of co-authors of Carmen Visús

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Visús. A scholar is included among the top collaborators of Carmen Visús based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Visús. Carmen Visús is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erhart, Friedrich, Tamara Weiss, Katrin Fischhuber, et al.. (2019). Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production. Cytotherapy. 21(6). 643–658. 7 indexed citations

Erhart, Friedrich, Johanna Buchroithner, Katrin Fischhuber, et al.. (2018). Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. Acta Neuropathologica Communications. 6(1). 135–135. 43 indexed citations

Schuler, Patrick J., Malgorzata Harasymczuk, Carmen Visús, et al.. (2014). Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer. Clinical Cancer Research. 20(9). 2433–2444. 120 indexed citations

Mandapathil, Magis, Carmen Visús, Olivera J. Finn, Stephan Lang, & Theresa L. Whiteside. (2013). Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells. OncoImmunology. 2(7). e25514–e25514. 5 indexed citations

Szajnik, Marta, Mirosław J. Szczepański, Esther Elishaev, et al.. (2012). 17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma. Gynecologic Oncology. 127(3). 587–594. 25 indexed citations

Visús, Carmen, Yangyang Wang, Antonio Lozano-León, et al.. (2011). Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells. Clinical Cancer Research. 17(19). 6174–6184. 129 indexed citations

Visús, Carmen, Rajiv Dhir, Mirosław J. Szczepański, et al.. (2011). Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas. Cancer Immunology Immunotherapy. 60(7). 919–929. 14 indexed citations

Butterfield, Lisa H., Charles Lee, Carmen Visús, et al.. (2011). Function but not phenotype of melanoma peptide‐specific CD8⁺ T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696). International Journal of Cancer. 131(4). 874–884. 20 indexed citations

Gangopadhyay, Nupur N., James D. Luketich, Carmen Visús, et al.. (2011). Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines. Cancer Investigation. 29(9). 608–616. 15 indexed citations

10.

Rahma, Osama E., Malgorzata Czystowska, Marta Szajnik, et al.. (2011). A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. Cancer Immunology Immunotherapy. 61(3). 373–384. 79 indexed citations

11.

Sakakura, Koichi, Carmen Visús, Joseph H. Schwab, et al.. (2010). CSPG4 in Cancer: Multiple Roles. Current Molecular Medicine. 10(4). 419–429. 97 indexed citations

12.

Rahma, Osama E., Malgorzata Czystowska, Marta Szajnik, et al.. (2010). Abstract 2414: Comparable effect of p53 peptide vaccine in adjuvant or pulsed on dendritic cells in ovarian cancer patients: A gynecologic oncology group study. Cancer Research. 70(8_Supplement). 2414–2414. 1 indexed citations

13.

Albers, Andreas E., et al.. (2009). Spontaneous apoptosis of tumor‐specific tetramer⁺ CD8⁺ T lymphocytes in the peripheral circulation of patients with head and neck cancer. Head & Neck. 31(6). 773–781. 14 indexed citations

14.

Wieckowski, Eva, Carmen Visús, Marta Szajnik, et al.. (2009). Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes. The Journal of Immunology. 183(6). 3720–3730. 460 indexed citations

15.

Hendrickson, Ronald C., Vito R. Cicinnati, Andreas E. Albers, et al.. (2009). Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide. Cancer Immunology Immunotherapy. 59(1). 113–124. 11 indexed citations

16.

Ito, Daisuke, Carmen Visús, Thomas K. Hoffmann, et al.. (2007). Immunological characterization of missense mutations occurring within cytotoxic T cell‐defined p53 epitopes in HLA‐A*0201⁺ squamous cell carcinomas of the head and neck. International Journal of Cancer. 120(12). 2618–2624. 27 indexed citations

17.

Visús, Carmen, Raquel Andrés, José Mayordomo, et al.. (2007). Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma. Melanoma Research. 17(2). 83–89. 39 indexed citations

18.

Visús, Carmen, Andrew A. Amoscato, Rajiv Dhir, et al.. (2007). Identification of Human Aldehyde Dehydrogenase 1 Family Member A1 as a Novel CD8+ T-Cell–Defined Tumor Antigen in Squamous Cell Carcinoma of the Head and Neck. Cancer Research. 67(21). 10538–10545. 116 indexed citations

19.

Steinberg, Seth M., Theresa L. Whiteside, Malgorzata Czystowska, et al.. (2007). A randomized phase II p53 vaccine trial comparing subcutaneous direct administration with intravenous peptide-pulsed dendritic cells in high risk ovarian cancer patients. Journal of Clinical Oncology. 25(18_suppl). 3011–3011. 9 indexed citations

20.

Ito, Daisuke, Andreas E. Albers, Yong Zhao, et al.. (2006). The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4+ Th Cells Capable of Enhancing the Ex Vivo Expansion and Function of Anti-wt p53264–272 Peptide CD8+ T Cells. The Journal of Immunology. 177(10). 6795–6803. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact